CHARLESTON, SC -- (Marketwire) -- 11/14/12 -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) will exhibit the Company's RevVac Auto-Retractable Vacuum Safety Syringe at the World Medicine Forum and annual conference for 2012 MEDICA November 14-17 in Düsseldorf, Germany ("MEDICA").
At MEDICA 2012, one of the world's largest medical trade fairs, a total of 4,554 exhibitors from 64 countries plan to present innovations for increasing the quality and efficiency of ambulatory and stationary care, with an anticipated total of over 230,000 attendees. The MEDICA conference takes a leading role as a barometer and platform for the activity of the global medical market, with a focus on international procurement concepts and global competitiveness that deal with the balancing act between the increased need for medical supplies on the one hand and limited resources on the other.
Ron Wheet, Chief Executive Officer and Chairman, stated, "This is our third MEDICA trade show in Düsseldorf, Germany. In 2010 and 2011, the RevVac safety syringe was introduced to the world health care market and to select international distributors to gauge preliminary sales interest and to confirm the benefits and value of this next generation of syringe technology. At this year's conference, we have prearranged meetings with several interested international distributors, and we are looking forward to meeting with our current and prospective customers."
The Company will demonstrate and exhibit the RevVac safety syringe at booth 16E26-4. The Company's contract manufacturer, Yeso-med, will also be joining Revolutions Medical at the show. The Company invites all attendees and prospective distributors to stop by booth 16E26-4 to see the auto-retractable vacuum safety syringe designed to create a higher standard of healthcare.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac safety syringe, safety blood drawing device, the RevColor, RevDisplay, and Rev3D software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled auto-retraction vacuum safety syringes.
For additional information, please visit Revolutions Medical corporate website:
To be added to the Revolutions Medical investor email list, please email:
email@example.com with RMCP in the subject line.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.